DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Buonerba C, Dolce P, Iaccarino S. et al.
Outcomes associated with first-line anti-PD-1/PD-L1 agents vs. sunitinib in patients with sarcomatoid renal cell carcinoma: a systematic review and meta-analysis.
Cancers (Basel 2020;
12 (02) E408
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.